PSGL-1 was significantly reduced on EMRA CD8+ T cells in the CFS/ME patients in comparison to the nonfatigued controls (Figure 3). The gene discussed is CD8A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.